Starting Hormone Therapy: What the First Six Months Actually Look Like
What the first six months of menopausal hormone therapy actually look like — workup, risk conversation, and follow-up with an MSCP-certified physician in Fairlawn.
Last updated: September 2026
Most articles about hormone therapy try to answer whether you should consider it. This one assumes you have already been thinking about it, maybe for a while, and what you actually want to know is what happens after you book the appointment. Who asks what. What gets checked. How long before anyone adjusts anything. How you reach a physician when something feels off in week five. I prescribe and manage hormone therapy in this practice, so this is a walkthrough of the process as it runs here in Fairlawn, from the first conversation through the six-month mark.
Being Told You Are Too Young
This is the single most common thing I hear in a first menopause visit. She is 44. She has not missed a period, or she has missed two. Her sleep fell apart eighteen months ago. She brought it up, and she was told to come back when her periods stop.
That advice misreads the biology. Symptoms frequently begin during perimenopause, years before a final menstrual period, and they do not politely wait for a clean endpoint. In the Study of Women's Health Across the Nation, Avis and colleagues followed 1,449 women with frequent hot flashes and night sweats and found a median total duration of 7.4 years, persisting a median of 4.5 years past the final period. For women whose symptoms began while they were still premenopausal or early perimenopausal, the median total duration exceeded 11.8 years.
Eleven years is not a phase to wait out. If that is where you are, you have written about your own experience more accurately than the five-minute visit did. I have covered the distinction between perimenopause and menopause and the symptoms that get dismissed in more depth elsewhere.
It also helps to know that the gap you ran into is structural, not personal. A survey of family medicine, internal medicine, and obstetrics and gynecology residents published in Mayo Clinic Proceedings by Kling and colleagues found that only 6.8 percent of respondents felt adequately prepared to manage women experiencing menopause, and one in five had received no menopause lectures at all during residency. Most physicians were never taught this. Certification through The Menopause Society exists precisely because the standard curriculum did not cover it.
The First Visit Is Mostly Listening
A first hormone therapy visit here runs long, and the majority of it is conversation rather than examination. What I am building is a picture, and the picture requires detail that a fifteen-minute slot cannot hold.
What I ask about:
Your cycle history over the past two to three years, including changes you may not have thought were relevant
Sleep, in specifics. Trouble falling asleep and waking at 3 a.m. drenched are different problems.
Mood, anxiety, irritability, and whether the pattern tracks with your cycle
Cognitive changes, including the word-finding trouble women are often embarrassed to name
Joint aches, vaginal and urinary symptoms, changes in libido, and skin changes
Your personal history of blood clots, stroke, cardiac events, migraine with aura, liver disease, and any hormone-sensitive cancer
Your family history, in particular breast cancer, cardiovascular disease, and osteoporosis
Everything you take, prescription and otherwise, including supplements
None of that is a formality. Half of those answers change what is appropriate, and a few of them change it decisively.
“Women arrive expecting to defend the request. I am not there to be convinced. I am there to work out whether this is a reasonable option for you specifically, and to say so plainly either way.”
What Gets Ruled Out Before Anything Is Prescribed
Symptoms that look like perimenopause are not always perimenopause, and it is bad medicine to treat the assumption instead of the finding. Before I write anything, the sequence generally runs:
Thyroid evaluation. Fatigue, weight change, mood shifts, and temperature intolerance overlap heavily with the menopause transition. This gets checked, not assumed.
Anemia and iron status, particularly relevant if bleeding has been heavy or irregular.
Metabolic and cardiovascular baseline, including lab work and blood pressure. In this office I can also run an EKG when the history warrants one.
Screening status brought current. Mammography and any other age-appropriate screening should be up to date before starting therapy, not scheduled afterward.
A direct look at contraindications. Certain histories make systemic hormone therapy inappropriate. When that is the case, I say so, and we discuss what else is available rather than ending the conversation.
Sleep, mood, and stress assessed on their own terms. Sometimes hormones are one contributor among several, and treating only one of them produces a disappointing result.
If your labs are normal, that is information rather than a dismissal. Normal thyroid studies alongside real symptoms is often the finding that points toward the hormonal transition, not away from it.
The Risk Conversation, With Actual Context
You deserve more than four minutes and a reference to a study from 2002.
The regulatory landscape shifted recently. On November 10, 2025, the FDA announced it was initiating removal of the broad boxed warnings from menopausal hormone therapy products, working with manufacturers to remove label references to cardiovascular disease, breast cancer, and probable dementia. The agency is not removing the boxed warning regarding endometrial cancer for systemic estrogen-alone products.
The Menopause Society responded that the warning may have deterred appropriate use, while stating clearly that systemic estrogen still carries potential risks in certain individuals that should be reviewed in detail, and that risks are lower for younger, healthy women initiating therapy closer to the menopause transition and greater when therapy is initiated in older women. Ms.Medicine has published a plain-language explanation of the label changes if you want the fuller version.
What that means in an exam room is that risk is individual, not categorical. Your age, how far you are from your final period, your cardiovascular picture, and your personal and family history all move the assessment. My job is to walk you through where you personally land, in language you can repeat to your spouse that evening, and to be honest when the answer is that hormone therapy is not the right choice for you.
Weeks Four Through Twelve: The Adjustment Period
Starting is not the end of the process. It is the beginning of a calibration that usually takes a couple of months.
Some symptoms respond earlier than others. Some women feel a shift within a few weeks. Others need an adjustment before anything meaningful changes, and a first plan that needs revising is an ordinary clinical event rather than a failure. What matters is that the revision happens on a reasonable timeline instead of at your next available appointment in eleven weeks.
Here that means you text me. Not a portal message that routes to a queue. If something feels wrong in week five, week five is when we deal with it. That access is most of what people are actually buying in a model built around longer visits and direct contact.
Months Three Through Six: What Follow-Up Looks Like
By the three-month mark we should have a plan that fits. From there, follow-up is about confirming it still fits.
A structured check-in on symptoms, using the same specifics we started with so the comparison is real
Blood pressure reviewed, and repeat lab work where the clinical picture calls for it
A conversation about anything that has changed in your health or your medication list
Reassessment of whether the plan should continue as is, be adjusted, or be reconsidered entirely
Bone health, cardiovascular risk, and screening folded back in, because hormone therapy does not sit apart from the rest of your preventive care
This is the piece a standalone hormone service structurally cannot deliver, because it requires someone who is also managing everything else. Menopause care is not a separate specialty visit bolted onto your life. It is one part of the different approach your forties and fifties call for.
How to Tell Whether a Hormone Service Is Legitimate
If you are comparing options online, these are the questions I would ask:
Is there a licensed physician or advanced practice clinician who will actually know your name and your history?
Is lab work reviewed before anything is prescribed, or does a questionnaire alone produce a prescription?
Is there a real follow-up schedule, or does the relationship end at fulfillment?
Does anyone ask about your family history, your screening status, and your other medications?
Can you reach a clinician between visits, and how quickly?
Is the clinician certified in menopause medicine, or trained in it in some documented way?
Are you being sold a product, or offered a plan that might reasonably conclude with "not this"?
A service that cannot answer most of those is selling access to a prescription. That is a different thing from care.
What You Should Expect From Whoever You Choose
You should expect to be believed on the first visit. You should expect a workup before a prescription. You should expect the risk conversation to be about you rather than about a headline. You should expect the plan to be adjusted when it needs adjusting, and you should expect to be able to reach the person who wrote it.
If you would like that here, you do not have to join the practice to start. The women's health consultation at West Side Concierge Medicine is a $425 standalone visit designed exactly for this conversation, and it is the entry point most women use before deciding anything about membership.
To schedule, call 330-593-2273 or visit wscmakron.com. If you are searching for a menopause specialist near you in Akron, Fairlawn, or elsewhere in Summit County, I am glad to be the one who finally has time for the whole question.
This article is for general educational purposes and is not medical advice. It contains no dosing information and no treatment recommendations for any individual. Hormone therapy is not appropriate for everyone. Discuss your own history with your physician.
